Find out more about how we meet the challenges of research, development and manufacturing data management.
Do you have a vision for clean, contextualized data? Is IT accountable to the bench in your lab? Are you willing to value even the most unassuming insights?
Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
Get a solid understanding of how modern data capture, verification and analysis techniques can drive better monitoring programs for commercial manufacturing.
Janssen looks at external and internal data sharing as a win-win application of digital technology that enables external manufacturers to perform optimally, while sponsor companies benefit from enhanced reliability, lower cost, and better assurance of quality.
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
From ensuring data integrity to consolidating IP ownership, effective data management is key for BioPharma companies seeking a competitive edge.
Join us on the 30th November, to discuss best practices for addressing this challenge and explore the use of innovative solutions to streamline process data management with higher data integrity, support accelerated tech transfer between development and manufacturing, and drive collaboration among internal and external teams.
i3 our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation is coming to Japan.
A cloud-only approach provides many benefits, including streamlined validation, automated backups and upgrades, faster deployments and flexibility.
A digital data backbone can improve efficiency in the research process leading to earlier discoveries and lower costs. Discover how now.
IDBS will be exhibiting in the event this year in Orlando, FL, at booth #1138. We look forward to seeing you there!
IDBS attended EBF in Barcelona. You can still book a meeting with one of our specialists.
Successful tech transfer can be a challenge, even for well-established biotechs. Here’s how to avoid common pitfalls at every stage.
Modernized data governance ensures a solid foundation of data integrity and compliance and achieves an integrated approach to the BioPharma data lifecycle.
Now that we know what a microservice is and why it’s important, let’s explore deploying and managing cloud microservices in GxP environments.
Speeding up time to insight throughout the BioPharma lifecycle requires all data sources to be connected and utilized to form a robust data backbone.
Join IDBS at booth E2 at the ELRIG conference in London, Europe’s largest meeting for life sciences industry professionals.
What is a microservice? Let’s explore the term’s meaning, the benefits and how it can help boost your data security.
IDBS will be running our annual experience event, i3, again in June this year!
Life science companies rely on data integrity, security and transparency to ensure success. How do we protect data while keeping it accessible?
BioProcess International took place in Vienna this year, with talks centred around six main streams including cell line development and engineering, cell culture, recovery and purification, viral safety, cell and gene therapy as well as smaller sessions for manufacturing strategy and Industry 4.0 and vaccine manufacturing.
IDBS, a global life sciences software company and the leading innovator in BioPharma Lifecycle Management (BPLM), is excited to bring together over 200 customers, partners and industry experts, including leading CxO and BioPharma companies, at their annual i3 user conference.
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
IDBS will be presenting at the conference this year in Vienna. We look forward to being back at Bioprocess in-person events in 2022.
Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
Gain key insights on the value of using purpose-built software systems to streamline your critical manufacturing data management and product quality processes across internal and external networks.
IDBS announces the latest release of its Skyland PIMS software, which seamlessly combines product, process, and patient data across the BioPharma life cycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
It’s been a busy year so far. And we’re only at the start of April! Find out what we’ve been up to in this blog.
Book your meetings with IDBS and Scitara at the IOT & Smart Pharma Summit this year in San Diego, CA. We look forward to being back in person and virtually in 2022.
Accelerate process understanding and time-to-insight across your development and manufacturing lifecycle. Join us at booth #21 at the Biomanufacturing World Summit in San Diego, USA.
IDBS will be running our annual experience event, i3, again in June this year!
Compared to most other industries, life science and biopharmaceutical companies have been slow to embrace digital technologies. Why?
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?
IDBS will be presenting at the event this year in Boston. We look forward to seeing you there!
While you may not find yourself Kitesurfing in Barbados, intuitive cell line selection unleashing powerful high throughput capabilities promises to be exhilarating.
IDBS will be presenting at the conference this year in Atlanta, GA. We look forward to being back at WRIB in person in 2022.
IDBS will be presenting at the event this year in San Francisco, CA. We look forward to seeing you there!
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and BioPharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But are they missing out?
Wondering if an ELN can be used as a LIMS? Hear from IDBS and other experts in this interesting piece published in Lab Manager.
Global life sciences software company, IDBS, is excited to publicly announce the location of our new Surrey HQ office address in Woking.
Join us for an interesting roundtable discussion around how to build a solid foundation for advanced analytics and why legacy ELN/LIMS aren’t suitable for modern biopharma because they don’t support the data backbone concept. Hear from experts at Accenture, GSK and IDBS and gather insight from experiences close to the ever evolving market.
Throughout the past few years, there’s been a clear trend in the makeup of approvals, with biologics representing a growing percentage. But even within biologics, newer technologies like mRNA, cell, and gene therapies are gaining ground. The approvals are not one-off events, but evidence of an exciting long-term trend. Learn more from Christian Marcazzo, General Manager at IDBS, in his article published in Drug Development & Discovery.
IDBS will be presenting at the event this year in Berlin, Germany. We look forward to seeing you there!
A top ten CRO (Contract Research Organization) has chosen IDBS’ Polar™ BioPharma Lifecycle Management to achieve its goal of faster biopharma development.
IDBS will be presenting at the conference this year in Boston, MA. We look forward to being back at Bio-IT in person and virtually in 2022.
Around this time last year, the first COVID-19 vaccines were authorized for emergency use. A year before that, COVID-19 had not yet been declared a pandemic. It goes to show how much can change in this industry, as well as how important this sector is. Hear predictions from experts, including Alberto Pascual, in this article, published in Drug Discovery World.
For those of us who develop software that supports the biopharmaceutical/life science industry, the challenges and opportunities in digital transformation are painfully obvious and it can be easy to forget that not everyone sees it that way. Let’s try another way…
IDBS will be presenting at the conference this year in San Diego, California. We look forward to being back at Bioprocess in-person events in 2022.
This webinar will discuss the progress made in the operational analytics and data space and the real benefits to its system administrators and speadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about the capabilities available to them. And E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud as well.
While 2021 was another challenging year in many respects, the life science industry still managed some notable achievements.
Tomorrow’s Connection Today – Designing a new future for manufacturing, quality and supply chain leaders. We will be attending the European Biomanufacturing Summit virtual conference on February 8-10, 2022.
Watch our webinar, Managing the Journey from Process Development to Insight, where you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.
Join Henry Charlton, Commercial Director Biologics to learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight and time to commercial readiness with advanced data analytics and visualization tools.
IDBS, a global life sciences software company and Synthace, a pioneer software for automated biology experimentation and insight sharing, have entered a strategic partnership to provide IDBS Polar users with state-of-the-art data foundations for experimentation in high-throughput process development (HTPD).
IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
When you factor in the unpredictability and complexity of therapies like biologics, the time impacts of poorly managed data are on the order of 6–18 months. Find out more on why legacy data management systems can’t support the directions…
IDBS will have a booth at the 14th Annual European BioAnalysis Forum in Barcelona.
The global community await to hear what the accelerated response to climate change will be from the COP26 Summit starting on Sunday in Glasgow. Here at IDBS we know that identification of true reductions in environmental impact through process modelling and Life Cycle Assessment can only be made with access to quality data. Find out more in our blog.
Join over 400 scientific leaders at Cell UK: In-Person Congress, connecting regenerative medicine and bioprocessing experts to transform cell research and therapies.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), announces its membership of BioPhorum. BioPhorum offers a space where biopharmaceutical manufacturers and suppliers can come together and discuss the many challenges in the industry, working collaboratively to address them. IDBS has joined the Information Technology Phorum (BPIT) which specifically addresses IT business goals.
Europe’s leading bioprocessing event for accelerating biologics, mAbs, vaccines and novel products to commercial success. Access leading science, technologies and contacts across the entire bioprocessing spectrum.
i3 our premier annual event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation and this year we went virtual. During i3 you will gain insights from your peers using…
The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a…
India Digital R&D Lab Summit” is our premier annual event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation!
Life sciences companies are using digital twins for everything from drug discovery to manufacturing. Hear from a panel of experts at MedCity News’ INVEST Digital Health conference, moderated by Accenture, where companies, including IDBS, discuss how this capacity to…
This session will provide an overview of IDBS’s upcoming plans to embed the DLX platform within E-WorkBook Cloud to provide a scalable, enterprise-grade integration backbone for lab connectivity and workflow orchestration. Following the overview, there will be an open forum to discuss some of the challenges in delivering lab integration at scale and feedback on workflows / instrument classes that should be considered for initial prioritization.
Join IDBS’ Scott Weiss, Ph.D. for this panel discussion, “Oh, the Places You’ll Go!” How the Integration of Cloud-Native Platforms and ELN are Fueling Innovation in R&D, at the 20/15 Visioneers webinar with TetraSciences’ Chief Scientific Officer Mike Tarselli, Ph.D., MBA.
IDBS is excited for its upcoming analytics launch and will update attendees to the progress made in this space which will have real benefits to its system administrators and spreadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about new capabilities soon available to them – and E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud.
Join IDBS’ Alberto Pascual for this roundtable discussion, The Role of Digital Twins in Life Sciences, at the MedCity INVEST Digital Health virtual conference.
In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. As more and more companies are now recognizing, a fundamentally different approach is…
IDBS, a leading R&D technology and solutions provider and Tableau, the world’s leading analytics platform, announced a strategic partnership to integrate Tableau into the IDBS suite of products. The collaboration will be based on embedding Tableau’s visual and analytics capabilities into the IDBS product offerings.
Roundtable Discussion | IDBS Hosts the Best Practices in Bioanalysis Lab Informatics. Hear how industry experts like Nexelis, AbbVie, and ICON plc are tackling digital lab challenges
Danaher Chief Science Officer Jose-Carlos Gutierrez-Ramos explores how the biopharma rule book has been rewritten by the pandemic and what to expect from the future of genomic medicines in this exclusive new article for Pharmaceutical Executive magazine…
Alberto Pascual, IDBS, tells MedCity News how digital twins can help advance innovation in R&D…
There was a flurry of activity on social media in June when John Erickson et al. published in Biotechnology and Bioengineering on end-to-end collaboration to transform development and manufacturing of biopharmaceuticals.
i3 is our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation!
Managing bioprocess data is a complex challenge even if you run just a few experiments per month. With HTPD this can quickly scale up to hundreds of automated, parallelized experiments. Used effectively as part of a BioPharma Lifecycle Management strategy, the data generated from HTPD can accelerate development by supporting better decision making and reducing timelines.
Efficient data management is critical to meet the demand for fast drug development – especially today…
In this webinar IDBS will share how an innovative approach to biopharma lifecycle management supports true QbD and can accelerate development to bring products to market faster.
One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.
Join Alberto Pascual, IDBS’s Director of Data Science and Analytics where he will discussing how you can join the digital transformation revolution by democratizing the use of advance analytics!
In a recent Forbes article, Danaher’s Chief Science officer, Jose-Carlos Gutierrez-Ramos, described the impact of the COVID-19 pandemic as follows:“I believe the biopharma business model has fundamentally changed.
IDBS has always listened to its customers and used the feedback gathered to guide the development of product capabilities. In fact, it is one of Danaher’s core values. Being part of Danaher’s Life Sciences arm has reaffirmed the value and we are constantly looking to improve based on customers’ feedback.
IDBS are delighted to presenting at The 2nd Quality Science of Biologics Summit in Beijing on the 25th May. We hope to see you there!
Biopharma 4.0 is a bold vision, with smart factories and process automation, driven by real time data to constantly ensure quality and efficiency. The journey towards this vision starts with improving process understanding and characterization, supported by advances in…
In this webinar, Henry Charlton, Commercial Director of Biologics Development at IDBS will share how effective biopharma lifecycle management can drive speed and innovation in process development as labs struggle with the increases in data from equipment, instruments and sensors.
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy, Cell Therapy & Vaccines
Meet us virtually for the 15th WRIB Annual Conference where high quality, better compliance to regulations and scientific excellence have always been the foundations of WRIB.
The public consciousness has been flooded with awareness of the previously niche concerns of quality control in drug manufacturing.
TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate IDBS E-WorkBook and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation.
LabVoice, which provides a workflow engine for scientific voice assistants, and IDBS, a leading R&D technology and solutions provider, are excited to announce an integration to accelerate research, innovation, and design.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), today announced the launch of Polar BioAnalysis, bringing consistency, quality, and reproducibility to preclinical drug qualification.
Asia’s leading bioprocessing event for learning how to drive down costs, improve timelines, and navigate the regulatory landscape for your biologics and novel modalities.
Learn How BioProcessing Experts are Increasing Quality, Process Efficiency and Productivity While Decreasing Costs to Achieve Commercial Success
Join Henry Charlton, Commercial Director, Biologics Development for for IDBS, at 11:00 am (JST) on April 6th to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The leading virtual event for learning how to improve process efficiencies and maintain product quality across all phases of bioprocessing.
Join Unjulie Bhanot, Solution Owner for IDBS, at 11:55 am PST on March 31 to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA — January 12, 2021 — Genedata and IDBS, both…
Guildford, UK and Framingham, MA, September 9th, 2020 – IDBS announced today that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new…
The ultimate goal in the biopharma space, especially for vaccine manufacturers, is producing safe and effective therapies faster, and at a lower cost. Many professionals still believe that their competitive edge relies on technical improvement, but it’s more complicated than that…
Join us at EBF, for the 14th meeting, focussing on the power of Science as our universal language. You can find us at the exhibit in the main conference expo hall, or catch one of our luncheon presentations. EBF 2020…
Join us at PEGS Boston, the leading conference & expo where world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions convene every year to transform the future of biologics. You can find us at the exhibit…
In response to the outbreak, governments around the world have put strict measures in place to limit the spread of the virus – Italy was the first country to order a country-wide lock down, France closed its borders and PM…
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy & Vaccine Assays High quality, better compliance to regulations and scientific excellence are always the foundations of this workshop. IDBS helps deliver consistency, quality and reproducibility for Preclinical…
Join us at Bio-IT World 2020, the leading conference and expo uniting life science, data, informatics, and IT leaders. You can find us at exhibit #326 in the main conference expo hall, or catch one of our luncheon presentations…
The Leading International Composites Show The JEC Group decided to postpone the 2020 edition of JEC World from May 12-14, 2020 to March 9-11, 2021. JEC Group is the world’s leading company dedicated entirely to the development of information…
BioAsia 2020 explores the capabilities that Life sciences companies should invest in today to thrive and create value tomorrow. Globally, the rise of more informed healthcare consumers, new technologies, and ubiquity of data and analytics continues to blur the…
Increase efficiency, enhance connectivity and drive superior quality in the modern lab. We’re delighted to be partnering with IQPC again in 2020 to bring you SmartLab Digital on 11th and 12th March. SmartLab Digital is a complimentary online series…
Join us at Analytica 2020, the world’s leading trade fair for laboratory technology, analysis, biotechnology and analytica conference. You’ll find us sharing booth space with our fellow Danaher operating companies Molecular Devices and Pall in Hall A3 covering Biotechnology…
IDBS, a software informatics solution provider for biotech and pharma, has expanded its global reach in India and made two strategic hires in the region. The latest move by the firm is in response to growing demand and an expanding…
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends…
Western CROs continue to up their game. They are offering unique services in a marketplace where the big CROs of the east are providing an unsurpassed scale of resourcing to support the externalization of discovery services. I believe there is…
This year BioProduction Congress merges with bioLIVE to become BioProduction at CPhI Worldwide. BioProduction will be co-located with CPhI Worldwide in Frankfurt, 5th-7th November 2019 – the largest pharmaceutical event in the world – uniting biotech, pharma, and solution…
Want to know a secret? In September we hosted a very large group of IDBS customers from the US at i3 Nashville. Customers from every R&D industry sharing experiences, lessons learned, and business challenges. So, are you going to…
We sat down with Chelsea Hyde, Field Marketing Manager for North America at IDBS, to find out what i3 means to IDBS, and what to expect at future events. What does i3 mean? When we were coming up with…
IDBS becomes the first Electronic Lab Notebook provider to achieve SOC 2 compliance IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants’ (AICPA) Trust Services Criteria…
We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits of attending i3 are, and how it fits into his vision for IDBS. What are some of the benefits to customers attending the i3…
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use…
IDBS enables research and innovation (R&I) teams to accelerate data capture, analysis and scientific decision-making and reduce the time to market of innovative, cost-effective new products to millions of customers worldwide. You can find out more about our approach to…
We sat down with J.T. Kaminski, Customer Success Manager at IDBS, to find out what i3 means to IDBS, and what he sees for the event’s future. What’s the most eye-opening thing you’ve seen at i3 last year? I’d…
Eighty-five. That’s the number of warning letters the FDA issued in 2018 alone. And of those letters, 49% were surrounding data integrity. This highlights a serious issue: there are data integrity deficiencies in the lab environment. With so many warning…
We sat down with Brady Haggstrom, Product Manager at IDBS, to find out what i3 means, and its highlights. What do you look forward to most about coming to i3 events? I look forward most to talking with customers and hearing about their challenges, what…
In our last blog post, we took a dive into the 2019 draft of the ICH M10 Bioanalytical Method Validation Guideline, the changes made, and how they affect scientists working at the bench. In this follow-up post, we’ll see…
The International Council of Harmonisation (ICH) has released a draft new guidance for bioanalytical method validation, and it has created quite a buzz, exemplified in a webinar hosted by Bioanalysis Zone. A panel of experts came together to discuss…
Historically, small molecule pharmaceutical products dominated the medical drugs market, from treatments for diabetes to broad-spectrum antibiotics, they worked, and the pharma industry bloomed. However, in today’s day and age, as the prevalence of different types of diseases and…
The latest version of ActivityBase and ActivityBase XE version 9.5 has been released to customers. This forms part of IDBS’ regular bi-annual product release and continues our investment into ActivityBase, supporting our large top pharma and biotech customer base. Over…
The importance of data integrity The research and development (R&D) industry has a responsibility to ensure the drugs they produce are safe, effective and high quality, and data integrity is key to making that happen. But it’s not always…
When you think of a medication, is the active ingredient the first thing that pops into your head, or perhaps the name of the drug? You’re not alone. The active ingredient of a medicine gets all the attention, which…
Writing for Scientific Computing World, Graeme Dennis says we should move away from the traditional definitions of informatics software. You can read the article here.About IDBSContact us More news…
In an online exclusive for EPM, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data. Read the article here.About IDBSContact…
Science is based on evidence, but the scientific research field is facing a reproducibility crisis. The science journal Nature published a survey in 2016, which demonstrated more than 70% of researchers could not replicate their peers’ studies in well-controlled…
Getting a product to market has always been a challenge. Discovering something new is just the beginning. After that, there’s the issue of securing the funding to bring the idea to life – the research, manufacturing processes, and pushing it…
The biologics market – medicines made from biological living systems through biotechnology – is trending. There’s no doubt about that. And the numbers back it up. According to a report by Market Research Future, the global biologics market…
Organizations in the biologics landscape face several challenges in the race to get their product to market, including handling their data efficiently. We have a solution… Industry growth presents challenges The continued growth in the biologics sector has…
When one thinks of the pharma and biopharma markets, one thing stands out – growth. In recent years, driven by necessity, advances in technology and ultimately funding, there has been a focused effort to transform our approach to medicine…
E-WorkBook is an electronic lab notebook that forms part of the IDBS cloud-based solution to manage your scientific data. Designed to replace the traditional paper lab notebook, information is stored electronically and so can be accessed and searched effortlessly…
We are just two weeks away from our Early Bird deadline for tickets to our i3 events in Nashville and London this year. Book before 31st May and you’ll get 40% off our Standard or All Access Passes. Don’t…
The biologics landscape is modern and ever-changing – and it needs innovative solutions to keep up with growing demand. What’s needed is a far-reaching and comprehensive solution, that helps scientists effortlessly execute workflows and provides decision-driving insight. We…
Samples are the essence of laboratory life. All the tests performed, equipment required, and regulations followed; everything revolves around them. So, managing these samples and the materials that go along with them is paramount. When contemplating streamlining lab processes…
IDBS will be exhibiting at the Hesperia Hotel in Barcelona on the 20-22 November. We will be showcasing how our Bioanalysis Solution could help you at booth B22. The IDBS Bioanalysis Solution provides a complete suite of interconnected workflows…
Without heavy investment in research and development (R&D), the millions of new and innovative medical technologies, drugs and delivery systems developed each year would simply not happen. In 2018, the UK’s medical funding body – the Medical Research Council…
In this expert interview, Debbie Barklamb, Account Manager with IDBS, explains how she works with our customers, coordinating resources to help them successfully onboard IDBS software. This includes helping new customers adopt and roll out our software and ensuring…
In the past, searching for experiment data has been a challenge in the R&D space. Science laboratories can have hundreds of employees and perform an enormous number of experiments each year. While a lab notebook is indispensable to scientific…
A record number of visitors attended this year event, that ran from 2nd-5th April in Vienna. Those who attended were not only treated to the beautiful city views but also the most exciting and recent innovations advances in the…
CONNECTING SCIENCE, TECHNOLOGY AND BUSINESS TO OPTIMIZE BIOPROCESSING Come and visit us at booth #93 and hear Unjulie Bhanot speak at 9.30 on 4th April 2019. Register here. Opportunities to Optimize Data Management in the Biologics Development Lifecycle Join…
Are you involved in, or researching, novel bioanalytical solutions and innovations in drug discovery and development? Then WRIB is the place to be this April. Built on the success of the previous annual meetings, the 13th WRIB offers discussions…
Looking to explore the latest advancements in scientific processes and technology across the bioprocessing world? BioProcess International Europe this April has it all and much, much more. At IDBS, we’re delighted to sponsor, speak and participate at this conference…
The date when the UK should be leaving the EU, colloquially known as ‘Brexit’, is approaching fast. Despite the nature of this event, there is still a great deal of uncertainty around how it will happen, when and if…
In bioanalysis firms, there’s a lot of pressure to do more with less. This means there’s a huge focus on increasing throughput in the laboratory, and contracting the QC timeline – either by the training of scientists or the…
In 2001, the FDA published the first version of the Bioanalytical Method Validation (BMV) Guidance for the bioanalysis industry. Over the next 17 years, the FDA would come out with another draft document, followed by a final version in…
IDBS, a leader in enterprise scientific informatics platforms, is pleased to announce a new SaaS contract with Genevant Sciences Corporation, a leading biopharmaceutical company focused on the discovery and development of a broad range of RNA-based therapeutics across multiple…
Companies are facing increasing pressure to get drugs to market faster on a smaller budget. As a result, organizations are looking to capture data more efficiently and do the most with their data. SaaS provides a solution, tackling some…
Maximizing the use of IT through a digital transformation program is undoubtedly challenging for any sector. While many sectors have undergone this process by putting a data-driven approach in place, this has yet to be fully realized in pharmaceuticals…
How data, AI and machine learning can open the doors to drug discovery and advance personalized medicine. Developing personalized and precision medicine is the next breakthrough for drug developers – particularly for cancer treatments. A recent review paper, from…
i3 is our annual customer and user group meeting here at IDBS. Each year the event brings our community of R&D and IT professionals together to ignite insights, develop ideas, and advance scientific innovation for the future. Each day at…
In this interview, Unjulie discusses the challenges in the current biologics scene, from business problems through to generating data in the laboratory, and explains how The IDBS Bioprocess Solution can help tackle these issues. Rising competition in the biologics development…
Sadly, Bio Innovation is over for another year. But from our perspective, the event just keeps getting better and better! We feel this is testament to both the effort of the GBX summit team, especially Patrick Basanez for his…
IDBS Blog | 22nd January 2019 i3 2018 saw three days of inspiration, innovation, and powerful networking with IDBS experts and fellow IDBS customers. Want to be a part of it this year? Save the date and get ready for…
Recent years have seen automated technologies, such as machine learning and AI, really starting to take off. While these technologies are growing in popularity, we need to have realistic expectations. In an ideal world we could have voice-activated computers…
The global pharma industry has always been cautious when it comes to adopting new technologies. Returns on investment from research efforts are volatile and restrictive, ever-changing regulations add to a culture that is already slow to adopt. Despite this…
On October 24th, we welcomed our customers to our annual IDBS User Group Meeting: i3. This year, we chose a beautiful lakeside resort just outside of Austin, Texas, writes Christine Zubris, IDBS Customer Success Manager. While Austin experienced the…
Few technologies have leapt from science fiction to fact as quickly as artificial intelligence (AI). After years of build-up, and of promise and excitement, the high level of AI maturity, driven by high-performance computing power, is now ubiquitous. And…
Usually organizations implement new IT strategies and adopt new technologies to keep ahead of the competition. But one charity is implementing a cloud-first strategy with a difference. The aim? To cease operations completely. Julie Dodd, Director of Digital Transformation…
IDBS, a leader in enterprise scientific informatics platforms, today announced the appointments of Graeme Dennis as Pre-Clinical Pharma Commercial Director, Abhay Kini as Director of Product Management and April Pisek as Solutions Consultant. These appointments strengthen IDBS…
In September, Christian Marcazzo joined us as Vice President and General Manager. Christian will be responsible for the day-to-day running of IDBS and growing the Informatics Solutions business of the Danaher Life Sciences Platform. Watch the interview below to…
Disaster recovery and backups are an often overlooked, but critical, component of managing an enterprise application. Both options are required to prevent catastrophic loss of data. Disaster recovery requires either off-site or multi-site storage – and organizations typically backup…
As the biologics market matures at an expected growth of 7-9% through to 2022 – reaching $3.8bn, it substantially influences the CMO/CDMO market with notable mergers and acquisitions in the space. This year we’ve seen Catalent’s acquisition of Juniper…
The biopharma space is constantly evolving thanks to the scientific community’s commitment to innovation to seek out new cures and ways to improve our health. These innovations, however, are often held back due to the often-outdated nature of commercial…
We are delighted to have been selected as a Top 10 Enterprise Software Solution Provider 2018 in Pharma Tech Outlook magazine’s special edition of exceptional solutions providers that enable productive medical research. To determine the list, Pharma Tech Outlook considered…
Guildford, UK, 10th September 2018 – IDBS, a leader in enterprise scientific informatics platforms, today announced that Christian Marcazzo has joined the company as Vice President and General Manager, effective immediately. Christian will be responsible for running IDBS and growing…
Pharma and biotech companies have invested heavily in externalized research, development, and manufacturing in recent years – but their methods of sharing critical data are still rarely fit for purpose. Typically, collaborator data is simply packaged up in a…
Despite shrinking growth in the pharmaceutical market, from double to single digit growth rates, demand for contract research organization (CRO) services is growing rapidly, according to the Business Research Company’s (BRC’s) 2018 CRO Global Market Report. Affirming CROs are on…
In August we attended The BioProcessing Summit 2018 in Boston. The event saw more than 1,000 bioprocess professionals and business leaders from around the globe gather to share practical ideas and solutions on tackling today’s bioprocess challenges. Now in its…
Join IDBS at the 10th Annual Bioprocessing Summit in Boston on August 13-17th 2018. IDBS will be exhibiting at booth #613 The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today’s bioprocess challenges. Now…
In October 2017, we hosted our first ever i3 conference in North America. We enjoyed the event so much that i3 is back again this year – and this time we’re in Austin! So, why should you come to…
Pharmaceutical companies are under escalating pressure to significantly increase the number of drugs that reach the market within a shorter timeframe, but lack the infrastructure to do so. More than ever, companies need to partner with outside firms to…
At the dawn of bioprocess development, biopharmaceutical manufacturing, upstream and downstream primary processing were worlds apart. This is because, in the pre-biotech days of industrial bioprocessing, the professionals in upstream, usually biologists, microbiologists…
Understanding the volume and complexity of data created throughout the scientific process is key. Biopharmaceutical companies generate a vast amount of high-value process data that is typically stored in paper records, databases, electronic files and in the heads of…
These are exciting times in biologics. Since 1995, applications for biotech patents have increased 25% year-on-year and biologics currently make up more than 50% of drugs in development. And, with many big deals already on the ledger this year…
The quality of your bioanalytical process will determine the quality of your study and with the right solution, the process can flow seamlessly.
Strict regulations, tight budgets and changing compliance needs are forcing pharma companies to employ new technology. Many are turning to cloud technology because it provides true scalability and helps free up time and resources that can be refocused on…
Whilst capturing and recording valid and accurate data is important for any company in any sector, it’s essential for businesses operating in the Research and Development (R&D) industry. Recording and working with data that could potentially contribute to life-changing…
The amount of data that’s generated every day is staggering. According to an article published in Forbes magazine: “The volume of data is exploding. More data has been created in the past two years than in the entire previous…
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In his final blog, Scott looks at whether a single platform could be the way forward for your organization. Informatics platforms have…
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In this second blog, Scott examines the benefits of adopting an integrated platform. It doesn’t matter if you are a large pharma…
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharmaceutical drug development. In this first blog, Scott examines the market challenges and obstacles businesses face when trying to get to market faster…
Following Fierce Biotech’s story revealing $10 million has been raised to bring a $4,000 lab robot into the mainstream, we delve into the driving factors that are required to make process and system automation commonplace in the pharma and…
The Biologics sector is continuing to grow at an accelerated pace – and it’s showing no signs of slowing down. Just recently, Pharmaceutical Product Development, LLC (PPD) announced the expansion of its GMP analytical laboratory, nearly doubling its analytics…
In a recent Q&A with Drug Target Review, we take a look at the key trends currently shaping the development of laboratory informatics software. Read moreAbout IDBSContact us More news…
With AI already integrated into our daily lives, Laurence Painell delves into the current landscape of AI development in the lab environment – from natural language processing to self-calibration of instruments. Read moreAbout IDBSContact us More news…
As you’ll probably know, today is International Women’s Day. This is a global day to celebrate the social, economic, cultural and political achievements of women. Women have played important and influential roles in the sciences and continue to do so here…
Join IDBS at Biotechnology Days, a conference that is co-organised by BIO Deutschland and the Council of German BioRegions. Since 2010, the organizers have put on the German Biotech Days, an annual two-day event that provides a forum for all…
Developments in bioprocessing and related analytical methods and technologies to progress biopharmaceuticals manufacturing Join IDBS in Prague where we are Gold Sponsors of this tradeshow. We will be speaking on the morning of the second day in the plenary session…
Facilitating the development and manufacturing of high-quality biologic drugs and vaccines in the Nordic region. Join us in Copenhagen at Biologics World Nordic on Booth Number 12 IDBS Associates: Graham Sanger – Head of Business Development Sarah Burgess – Field…
Join IDBS in Lisbon for the Global Pharma R&D Informatics Congress on the 30th November to the 1st December. IDBS are a gold sponsor and will have a booth and will be speaking during the congress. Increasing amounts of data…
Mammalian and microbial biopharmaceutical manufacturing Boost productivity and quality through innovation Join IDBS at BioProduction Congress and the Bioanalytical and Formulation Summit in Dublin on the 9th and 10th of October 2018. IDBS will be exhibiting and speaking in…
Transforming Research: A premier event for the European life sciences discovery and technology community Join IDBS at booth 602 on the 27th of June for the first Society for Laboratory Automation and Screening conference in Europe. About IDBSContact us More…
While drug research and development is often likened to finding a needle in a haystack, Paul Denny-Gouldson offers insight into the recent technological advancements that are already starting to shorten development deadlines. Read moreAbout IDBSContact us More news…
Pharmaceutical Technology includes IDBS as part of their assessment of the trends and technologies behind lab data integrity, mentioning the recent news of the synthetic chemistry extension to The E-WorkBook Cloud. Read moreAbout IDBSContact us More news…
Monday, April 9th – Friday, April 13th 2018 Sheraton Downtown Philadelphia A Week of Bioanalysis, Biomarkers, and Immunogenecity at WRIB Join IDBS and over 750 professionals representing pharmas/biopharmas, biotechs, CROs and multiple regulatory agencies working on both small and large…
Stop by IDBS booth #212 to say hello to our experts! May 15-17, 2018 | Seaport World Trade Center Boston, MA Don’t miss our luncheon presentation within the Cloud Computing track on Thursday 5/17. IDBS’ Vice President of Product Strategy, Dr…
Monday, April 30th – Friday, May 4th 2018 Seaport World Trade Center – Boston, MA Stop by IDBS booth #210 to say hello to our experts! Our booth will be located next to Molecular Devices @ booth 212. More…
Join us at the 14th Annual APA Meeting October 1-3, 2018.About IDBSContact us More news…
Meet with IDBS at the annual Smart Lab Exchange February 20 – 21, 2018 in San Diego, CA. #SmartLabExchange Download the top investment priorities for 2018 to find out what the top challenges and investment areas are for lab…
Join IDBS at Molecular Med Tri-Con February 12-14th in San Francisco. Since its debut in 1993, the conference has become one of the world’s leading international events in the field of drug discovery, development and diagnostics. Spanning five days…
As you may have seen in the news last week, a major security vulnerability was announced potentially allowing unauthorised individuals to gain access to privileged information via a vulnerability with modern day processors. The announcement was made early Thursday…
Getting a data security strategy right is critical for any business. In the final blog of his data security series, Scott Hluhanich explains what you need to know. As presented by Gartner in the Top Security Trends for 2014-2015…
Our final lab diary entry for EPM Magazine examines how emerging technologies will solve annoyances in today’s laboratory. Read More About IDBSContact us More news…
Insider threats present an urgent problem which can be addressed with the help of appropriate technology. In the second blog of his data security series, Scott Hluhanich explores where these threats are originating. Sharing data through email and consumer-grade…
Paul Denny-Gouldson gives his insight into transfer of technology should include data and process information – leading the way to an effective knowledge exchange. Read MoreAbout IDBSContact us More news…
Data security is a hot topic for all businesses. In his first blog of three, Scott Hluhanich explains how security incidents are on the rise and discusses how much these incidents are costing businesses. In the 2015 US State…
Laurence Painell talks us through developments like automation, machine learning and robotics and how they will shape laboratories in the future. Read MoreAbout IDBSContact us More news…
Paul Denny-Gouldson gives his insight into how the role of the quality assurance (QA) and quality control (QC) units will change with new technologies like AI and the cloud. Read more About IDBSContact us More news…
The capabilities of Laboratory Information Systems (LIMS) have improved considerably in recent years, with more ways to manage samples and associated data. With the right LIMS, organizations can automate workflows, integrate instruments, produce results in a faster time, and…
Paul Denny-Gouldson highlights the need for firms which are looking to take advantage of process automation and the associated efficiency gains to first develop strategies to migrate, update or change their current systems. Read More.About IDBSContact us More news…
Paul Denny-Gouldson gives his insights into how the rise of instrument and process automation is leading to an increase in data – and how this can be leveraged in the future. Read More.About IDBSContact us More news…
Scientific Computing World covers IDBS’s latest product release, the Bioprocess Execution Solution, which takes advantage of the latest technology platform that IDBS offers to simplify working while ensuring regulatory compliance. Read More.About IDBSContact us More news…
Visit us at Booth 4 to find out how we can help you keep your informatics on track. Swap your business card for a free coffee or enter our Hot Wheels competition just in time for Christmas! Our VP…
Security is an obvious concern for research organizations. Moving data in and out of the building requires trust by all parties, which is difficult, especially when sharing data across different countries, offices and individuals. Before engaging in any collaborative…
With teams under pressure to develop new products faster and at a lower cost, it’s easy to see the appeal of robots for R&D organizations. Most lab processes are geared around the regular 9-5 working day, but with a…
Paul Denny-Gouldson kicks off his Huffington Post series with his thoughts on the impact of artificial intelligence (AI) in R&D. Read MoreAbout IDBSContact us More news…
In October, IDBS hosted our first ever i3 Community Forum in North America. You may have heard about it, or even attended. Usually, we hold three small regional forums across the region, but this year we tried something different…
In his epic novel Ulysses, author James Joyce wrote that mistakes “are the portals of discovery”. He’s wrong. Okay, it’s slightly contentious (and perhaps slightly ambitious) to call out a literary giant, but hear me out… In the pharmaceutical…
Joe Rajarao offers his insights to Scientific Computing World on the use of informatics software by contract research organizations (CROs). Read More About IDBSContact us More news…
GUILDFORD, UK, October 30th , 2017 – IDBS, a leader in enterprise scientific informatics platforms, today announced it has been acquired by the life sciences platform of Danaher Corporation (NYSE: DHR) (“Danaher”). IDBS is a leader in enterprise scientific informatics…
Ian Peirson gives his insights into how outsourcing in the pharmaceutical sector has become fundamental to research and manufacturing. Read MoreAbout IDBSContact us More news…
IDBS & ChemAxon presents the first joint Meet & Lunch in Paris: Why is it time to change your legacy ELN and Chemical Registration System? What does the IDBS and ChemAxon Strategic partnership mean in practice? We will effectively showcase…
The world we live in is ever-changing – just take a look at how technology has advanced in recent years. Some readers will even remember a time before the internet (oh the horror!), and yet, in a relatively small…
Our penultimate lab diary entry for EPM Magazine evaluates data safety and cloud computing, and why transition is a no-brainer. Read MoreAbout IDBSContact us More news…
For R&D organizations, data is the new GOLD. Historically, data has been captured in silos, so harnessing the power of data can be tricky – particularly for bioprocess organizations. Bioprocess data tends to be far more contextually rich than…
It is a truth, universally acknowledged, that chemists are creatures of habit. I should know: I am one. And, in the same way that many people have a favourite food, pair of shoes, or season of the year, chemists…
Jarrod Medeiros, Product Manager, gives his insights into the risks and rewards of transitioning to the cloud. Read MoreAbout IDBSContact us More news…
Laurence Painell, VP of Marketing, gives his thoughts on the benefits of increased data integrity in laboratories. Read MoreAbout IDBSContact us More news…
Stuart Ward, Head of Business Analysis, gives his thoughts on how pharmaceutical organizations can introduce automation while remaining compliant. Read MoreAbout IDBSContact us More news…
Jarrod Medeiros, Product Manager, outlines how IDBS is leading the way in data management, speaking to the publisher of BioProcess International. Read MoreAbout IDBSContact us More news…
Paul Denny-Gouldson, VP Strategic Solutions, outlines the future relationship between humans, processes and automated equipment, stating the case for automation. Read MoreAbout IDBSContact us More news…
Laurence Painell, VP of Marketing, outlines the modern technologies R&D labs can use to dramatically cut costs and transform their operations. Read moreAbout IDBSContact us More news…
Our popular Community Forums have been running for several years now, so we decided to mix things up a bit for our latest event in Brussels, at Solvay’s HQ! We transformed the event into a VIP interactive workshop with…
70% of scientists failed to reproduce at least one other scientist’s experiment. Our sixth lab diary entry for EPM Magazine explores if cloud technology can help with the reproducibility crisis in science. Read moreAbout IDBSContact us More news…
We are excited to be attending the Nordic Life Science Days event and we are looking forward to meeting with our customers and making new connections. Nordic Life Science Days 12-14th September 2017 Copenhagen If you would like to…
Ian Peirson, Head of Product Planning, offers his insights on how scientific organizations can lower costs and speed up the discovery process. Read More. About IDBSContact us More news…
Stuart Ward, Head of Business Analysis, looks at how costs in the laboratory can be cut without compromising on safety and efficiency. Read moreAbout IDBSContact us More news…
Laurence Painell, VP of Marketing, speaks to BioPharm International about ensuring data integrity in the laboratory using electronic systems. Read moreAbout IDBSContact us More news…
Stuart Ward, Head of Business Analysis, looks at how organizations can use validated software to improve efficiency and comply with regulation. Read moreAbout IDBSContact us More news…
Laurence Painell, VP of Marketing, looks at how the Internet of Things (IoT) is impacting laboratories globally. Read MoreAbout IDBSContact us More news…
Our fifth lab diary entry for EPM Magazine examines the four things pharmaceutical organizations need to consider before implementing integrated solutions. Read moreAbout IDBSContact us More news…
Jarrod Medeiros, Product Manager, assesses the opportunities and hesitations when outsourcing data centers. Read moreAbout IDBSContact us More news…
We are pleased to announce that we’ve made the shortlist at the Cloud Excellence Awards 2017, in the ‘Most Innovative Cloud Product or Service’ category. Although we’re up against some pretty fierce competition, it’s great to see that The…
The IDBS E-WorkBook Cloud has been shortlisted for Most Innovative Cloud Product or Service at the Cloud Excellence Awards 2017 Guildford, UK, July 20, 2017 – Today, IDBS, a leading R&D and scientific software solutions provider, has been announced…
We came across this whitepaper from Amazon Web Services (AWS), outlining their thoughts on GxP and exploring the compliance and efficiency benefits of rethinking regulated workloads. It’s an interesting read, and ties in nicely with our GxP offering so we…
Jarrod Medeiros, Product Manager, explores the benefits of automation and how it is changing the pharmaceutical industry. Read moreAbout IDBSContact us More news…
Joe Rajarao, Solutions Consultant, speaks with Bioanalysis Zone to discuss IDBS’ work and contribution to the pharmaceutical, life science and bioanalysis industry. Read moreAbout IDBSContact us More news…
In almost every facet of modern life, people are absent-mindedly producing and consuming data at an ever increasing speed. But the staggering quantity of data that is generated and utilized by an R&D organization needs careful management and thoughtful consideration…
A recent article in National Geographic Magazine, Why we Lie: The Science Behind our Deceptive Ways by Yudhijit Bhattacharjee, explores how and why scheming and dishonesty are part of what makes us human. We lie for all kinds of reasons…
We are delighted to invite you to the headquarters of our valued customer Solvay for this enterprise R&D interactive workshop. Join our experts and find out how you could move your R&D to the cloud. Date: 6th September…
Our fourth lab diary entry examines why pharmaceutical companies should be implementing cloud software – highlighting three reasons organisations should embrace the cloud. Read moreAbout IDBSContact us More news…
We have added E-WorkBook Request, our work request management platform, to The E-WorkBook Cloud! Naturally, we’re pretty excited, but we also know what you’re thinking: “So, what is it? What does it do? And why should I care?” Quite…
E-WorkBook Request allows researchers to track and schedule work with instant updates Boston, US, & Guildford, UK – June 14, 2017 – IDBS has launched E-WorkBook Request, a work requesting and orchestration tool. It is available as a new…
Jeff Tisher, Solutions Consultant, looks at how lab testing can be improved: from managing the testing process and streamlining services to data aggregation and maintaining compliance. Read moreAbout IDBSContact us More news…
Come and visit us at our booth, #37, for your chance to win, and chat to one of our experts about keeping your informatics on track. Also Don’t miss Dr Paul Denny-Gouldson’s presentation at 10.30 on the 18th of…
IDBS will be exhibiting at the IFT17 conference – Join us! Event Details Date: 25th-28th June 2017 Time: 10am–5pm Location: Las Vegas IFT is one of the world’s leading food science conferences and gives you the chance to discover the newest products, latest…
Rory Quinn, Solutions Consultant, discusses how cloud computing is changing the research and development process in the pharmaceutical industry. Read moreAbout IDBSContact us More news…
Our third lab diary entry for European Pharmaceutical Manufacturer looks at the importance of security, systems integration, compliance and industry expertise when choosing an outsourcing partner. Read moreAbout IDBSContact us More news…
Stuart Ward, Head of Business Analysis, outlines how labs can become safer and more efficient by adjusting workflows and practices. Read moreAbout IDBSContact us More news…
Laurence Painell talks to Tomorrow’s Laboratories about The E-WorkBook Cloud winning Cloud Product of the Year at the National Technology Awards and the benefits the solution gives to its users. Read moreAbout IDBSContact us More news…
Paul Denny-Gouldson shares his insight about the growing interest in cloud computing within pharmaceutical manufacturing.About IDBSContact us More news…
We are delighted to announce that The IDBS E-WorkBook Cloud has been named Cloud Product of the Year at the National Technology Awards in London. It is great to see our commitment to enabling organizations to operate faster, more…
The IDBS E-WorkBook Cloud has won Cloud Product of the Year Guildford, UK, May 19, 2017 – IDBS, a leading R&D and scientific software solutions provider, has been recognized by the National Technology Awards for its innovative cloud solution…
So, you think you need a LIMS to execute your solutions workflows? You’re not the only one. For years, a LIMS has been one of the ‘go to’ products to support laboratory operations. But, although the features of laboratory…
Despite breaking global sales records in 2015, biopharmaceutical companies are witnessing a slowing in growth and are under increasing pressure from payers and competitors to reduce costs. So, what’s the solution? Cost reduction initiatives often focus on process improvement…
Paul Denny-Gouldson discusses the applications and uses of CRISPR technology and the role cloud computing plays in data management.About IDBSContact us More news…
Jeff Tishler, Solutions Consultant, and Kevin Arnold, Senior Account Manager, discuss how accurate recording of research data and the ability to quickly search historical data can help food and beverage companies ensure food safety and compliance.About IDBSContact us More news…
Our second lab diary entry looks at the challenges scientists face when collaborating with other labs, starting routine procedures from scratch and the love hate relationship between scientists and their equipment. Read moreAbout IDBSContact us More news…
Outsourcing partnerships have changed dramatically over the past 20 years. Pharmaceutical drug discovery companies have finally embraced subcontracting as a way to harness strategic collaboration and expertise, and not just as a source of cost-effective labor. Outsourcing partners have…
When you think about research, it’s easy to overlook all the experiments that didn’t work or provided the wrong outcome. Just as chemical elements have an equal and opposite charge for protons and electrons, research results come in both…
From May 2017, the US Food and Drug Administration (FDA) will require all new drug and biological product submissions to be sent electronically. It’s a pretty big change – but are you really ready? And do you know how…
The 4th and 5th April saw the 5th annual Paperless Lab Academy conference take place in sunny Barcelona. Once again the idyllic location delivered, with wonderful weather welcoming delegates to the first day of the conference! The fact that…
Bringing time to market forward by a week can reduce out of pocket expenses by $6 million. Yes, really. $6 million. It seems so simple doesn’t it? Save time and save money. The questions is: ‘How?’ Rather than saving…
If you have been a scientist in a good laboratory practice (GLP) setting long enough, you’ll be familiar with certain buzzwords that carry ominous connotations – words like raw data, traceability, and the even scarier deviation. There is even…
Ok, let’s cut to the chase: more and more people say that Electronic Lab Notebooks (ELNs) are the “paper notebook of the future” and they’re not wrong! But with so many 3-letter acronyms in the world of scientific and R&D…
Today we announced we have now added a validatable service to The E-WorkBook Cloud platform. But what does this really mean for our customers? In short, the validation services we’ve been offering to our on-premise customers for over 30 years…
The IDBS E-WorkBook Cloud has been shortlisted for Cloud Product of the Year Guildford, UK, March 14, 2017 – Today IDBS, a leading R&D and scientific software solutions provider, has been recognized by the National Technology Awards for its…
IDBS now has a monthly feature in European Pharmaceutical Manufacturer, where we discuss lab challenges and solutions for scientific R&D organizations. Our first piece, “Lab diary no.1”, covers 1) working in a clean room and 2) using paper notebooks. Read…
As you may have seen in the news last week, AWS experienced some issues with the infrastructure it uses for some of its IaaS (Infrastructure as a Service) platform. Whilst IDBS was only minimally affected by this outage, we thought…
The E-WorkBook GxP Cloud can now be validated for streamlined regulatory certification Boston, US, & Guildford, UK, March 9, 2017 – After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified…
Technology Networks Speakers at Smartlab Exchange USA focused on the pragmatic approaches to lab informatics. Jarrod Medeiros, Product Manager, reveals the hot talking points from the conference in his article. Read moreAbout IDBSContact us More news…
PharmaVoice.com Scott Weiss, Vice President of Product Strategy, contributes his insight to PharmaVOICE’s Disruptive Technologies issue, sharing his knowledge and thoughts on fuelling innovation and transforming the industry for the future. Read his commentary on pages 18 & 20. Read…
Manufacturing Business Technology The cloud is of particular interest to manufacturing organizations looking to reduce their overall costs, but some still have security concerns. Vice President of Strategic Solutions, Paul Denny-Gouldson, discusses the comprehensive security of private…
So, you think to yourself: “I need an ELN!” You see the use of “ELN” here, “E notebook” there and occasionally the term “paper-on-glass” somewhere over there. How do you begin to start looking for the right electronic solution…
It’s an age-old debate: are two heads really better than one? At IDBS, we’ve long advocated bringing in the best possible expertise to make something better… but don’t just take our word for it. Fruitful partnerships are everywhere you look…
Strategic technology deal strengthens IDBS’ single R&D data management platform London, UK, Budapest, Hungary & Boston, US, February 22, 2017 – Today, IDBS announces that the strategic technology partnership with ChemAxon has been further strengthened. IDBS is now able…
Food Manufacturing From the accurate recording of recipes and formulations, to manufacturing and process controls, Paul Denny-Gouldson discusses the importance of proper data management in the food industry. Read moreAbout IDBSContact us More news…
When R&D data is managed in silos, it’s inevitable that transcription errors and inaccuracies will occur especially when moving data between systems, people and organizations. The problems seem obvious, don’t they? When data is spread across multiple systems, the ability…
Bioanalysis Zone What impact will outsourcing have in the bioanalytical industry? Paul Denny-Gouldson, Vice President of Strategic Solutions outlines some of the future trends we can expect to see in the bioanalytical outsourcing sphere. Read moreAbout IDBSContact us More news…
R&D Magazine Paul Denny-Gouldson, Vice President of Strategic Solutions, discusses how good data management can help support automation. Read moreAbout IDBSContact us More news…
Boston, US, New Haven, US & Guildford, UK, February 8, 2017 – Today, IDBS, a leading global provider of advanced software for R&D companies, announced that New Haven-based Achillion Pharmaceuticals has implemented the IDBS E-WorkBook for electronic laboratory data capture…
Our purpose: ‘To provide the best cloud-based R&D technology and solutions to the world’s most forward-thinking companies, helping them solve global challenges.’ When you go to work each day, we think you should be able to answer these three simple…
Boston, US, Durham, US & London, UK, January 25, 2017 – Precision BioSciences, a genome editing company based in Durham, North Carolina, has implemented IDBS E-WorkBook to improve its data capture and streamline innovation in cancer immunotherapy, gene therapy and…
Combining the most powerful R&D software platform with the benefits and flexibility of the cloud Boston, US & London, UK, January 12, 2017 – IDBS has today launched The E-WorkBook Cloud, an enterprise, Cloud-based platform designed specifically to meet…
Pharmaceutical Processing Laurence Painell, Vice President of Product Management & Marketing, discusses the growing trend of outsourcing in the pharmaceutical industry, the potential developments for 2017 and how organizations can prepare for them. Read moreAbout IDBSContact us More…
Drug Discovery World The combination of new biology techniques and cloud technology has resulted in the increased drive to transform the tools used to support biology research. Paul Denny-Gouldson, Vice President of Strategic Solutions, discusses the future of bioinformatics in…
Tomorrow’s Laboratories 2016 was a busy year for the pharmaceutical industry and Scott Weiss, Vice President of Product Strategy, reviews some of the industry’s interesting talking points. Read moreAbout IDBSContact us More news…
Laboratory Equipment Paul Denny-Gouldson shares his insight and best practices in Laboratory Equipment’s Last Word, for scientists maintaining their laboratory notebooks. Read moreAbout IDBSContact us More news…
Scientific Computing World Paul Denny-Gouldson discusses the challenges organizations encounter when formatting and sharing data across the scientific industry with Sophia Ktori. Read moreAbout IDBSContact us More news…
Pharmaceutical Processing Paul Denny-Gouldson discusses how biopharmaceuticals organizations can streamline the development of new therapeutics using tailored informatics. Read moreAbout IDBSContact us More news…
Outsourcing software development is a well-established industry trend. After all, “there’s always more to build than we have time or resources to build – always” (Jeff Patton,User Story Mapping, 2014). Outsourcing partners can be found all over the world, but…
Pharma IQ Paul Denny-Gouldson was a speaker at the 15th Annual Laboratory Informatics event in Brussels, where pharma companies gathered to discuss innovation trends. Read Paul’s article for Pharma IQ to find out the highlights of the conference. Read moreAbout…
Chemical & Engineering News Cloud computing is helping advance research and collaboration in the pharmaceutical industry and scientists are embracing the technology with both hands. Paul Denny-Gouldson spoke with C&EN explaining some solutions available for scientists. Read more…
Tomorrow’s Laboratories Technology is helping shape the design of the laboratories and how scientists operate in them. J.T. Kaminski, Director of Technology services EMEA, discusses what scientists can do to embrace the Lab of the Future (LotF) in his article…
Tomorrow’s Laboratories There are many aspects of the pharmaceutical industry that scientists find arduous. Paul Denny-Gouldson offers some helpful solutions in his article on pages 28 – 29. Read moreAbout IDBSContact us More news…
Tomorrow’s Laboratories The E-WorkBook Chemistry ELN is a comprehensive web-based solution to meet the needs of a chemist’s workflow, based on an industry-standard ChemAxon platform. C&EN explain more in the product review on page 39. Read moreAbout IDBSContact us More…
Drug Target Review Basel Life Science Week 2016 was a flurry of scientific intellect and innovation. J.T. Kaminski, Director of Technology Services EMEA at IDBS, contributed to it with his presentation on the ‘Lab of the Future’. Read his thoughts…
R&D Magazine How can pharma organizations use tech to protect against losing vital IP amassed by researchers in the company? Paul Denny-Gouldson discusses the best practices for the pharma industry to safeguard their research. Read moreAbout IDBSContact us More news…
Since the release of the E‑WorkBook 10.1.2 Chemistry ELN, we have been busy augmenting the core features of the stoichiometry table. One of the enhancements we have recently implemented is the calculations of solvent concentration, with the ability to determine…
G.I.T Laboratory Journal How does Germany compare to the rest of Europe when it comes to Cloud adoption? J.T. Kaminski, Director of Technology at IDBS, analyses Germany’s Cloud adoption habits in his feature for G.I.T Laboratory Journal. Read more About…
R&D Magazine Why are US organizations ahead of their European counterparts when it comes to Cloud adoption? J.T. Kaminski, Director of Technology Services EMEA at IDBS discusses the factors affecting US and European adoption of Cloud software in his article…
We’re very pleased to announce that the E-WorkBook Chemistry ELN has been released with v10.1.2 of E‑WorkBook in July. Considering we started from just design documents in January, the chemistry development team has worked hard to provide the user with…
IDBS has been developing a number of strategic partnerships over the past three years. This is part of our core strategy to ensure that our customers get the most appropriate tools and solutions to support their very diverse and scientifically…
We recently hosted a Special Interest Group meeting in Munich where, with a group of customers, we discussed how users can really get the most out of E-WorkBook. We focussed primarily on the web client, and explained how users can…
We were delighted to attend the Elrigfr conference in May, where we shared IDBS experience about Lab Automation, Formulation & Phenotypic screening. At the conference, we particularly enjoyed the Phenotypic Screening session, which featured presentations from NeoVirTech, Servier and…
We frequently store and update data within IT systems. But, do we ever truly consider what it will take to find this data when we need it again – in a week, a month, or even a year later? Consider…
Scientific Computing World How do you ensure the data produced by your CROs hasn’t been tampered with, and what systems can be put in place to protect your research. Paul Denny-Gouldson talks to Sophia Ktori about the options available to…
Earlier we wrote about the auto-text feature we provide in E-Workbook’s electronic notebook for chemists, which allows you to add predefined phrases to the procedure write-up with a single click. This functionality is now even more powerful! These phrases consist…
Scientific Computing World Robert Roe discovers that data integrity, process improvement, and managing data effectively are key challenges for informatics providers ‘finding the speed to innovate’, as the theme for the latest Paperless Lab Academy suggested. Read more About…
European Pharmaceutical Manufacturer Scott Weiss, Senior Director of Product Management, talks about the Internet of Things (IoT) and externalized research and development (R&D) and the affect on life sciences. Read moreAbout IDBSContact us More news…
Drug Discovery News We didn’t bring you any May flowers, but how about new protein sequencers, cloud-based R&D, correlative Raman-SEM imaging, a newly compliant handheld Raman analyzer and cloud-based monitoring and analysis of clinical trials? Read moreAbout IDBSContact us More…
Scientific research is changing. In order to increase the time to market, researchers want to break down the silos between departments, simplify the way they work and focus on doing science. However, their biggest frustration (especially in chemical research) is…
Chemists are always working with an end goal in mind – to conduct research efficiently and to reach a desired result. They need tools to plan, execute and record reactions, with access to historical experimental results to find new synthetic…
We believe that ‘Cloud is the future of R&D’. At Bio-It World 2016 in Boston, industry experts agreed with us! Labs of all sizes are increasingly realizing a raft of benefits the cloud can deliver, especially with regards to reducing…
R&D Magazine Scott Weiss, Senior Director of Product Management discusses what is necessary for innovation in the life sciences sector in his article for R&D Magazine. Read moreAbout IDBSContact us More news…
Specialized research and development (R&D) labs including contract organizations (CROs, CMOs etc.) in all sectors are under extreme pressure to develop new formulations quickly (as fast as possible) and effectively (as close to specification as possible). Responding to requests…
PharmaVOICE Scott Weiss, our Senior Director of Product Management, speaks with PharmaVOICE magazine about the ‘need for speed’ driving innovation in life sciences organizations. Read more About IDBSContact us More news…
PharmaVOICE Pharma organizations are up against a drive to innovate more than ever before. Scott Weiss, Senior Director of Product Management, explains how they are responding. Read moreAbout IDBSContact us More news…
IDBS sees rapid adoption of Cloud based services by small and mid-tier Pharma market Majority of large enterprise accounts planning migration to IDBS hosted Cloud over next 3 years E-WorkBook platform makes collaboration and data sharing simple Over 50,000…
The scenario is sadly only too familiar: management has decided on a project to transform the business that is ultimately unsuccessful. It’s true, companies need to adapt to keep up with new technologies and ideas, but, according to Forbes…
Breakthrough discoveries in research and development (R&D) are rarely a single individual’s feat. Collaboration paves the way for accelerated advancements, but most often comes up against concerns around data sharing security and the protection of intellectual property (IP). It’s…
Research and Development informatics is not that different to any other area, it is full of tools and software that are all given TLA’s (three letter acronyms) or even FLA’s (four letter acronyms). This is in response to a history…
Module facilitates efficient lab stock management, saving cash and time Boston, US & London, UK, March 22, 2016 – IDBS today unveiled E-WorkBook Inventory, a new module for streamlining lab inventory management. The off-the-shelf tool enables E-WorkBook users to…
As labs find themselves under constant pressure to reduce costs and save time, there’s a lot of talk around how organizations can streamline various lab processes. One area that often slips under the radar is inventory management. And yet, organizations…
At IDBS, we often speak about the significant competitive pressures that R&D organizations must tackle in today’s business environment. In this challenging global market, the established players must find new ways to deliver more innovation, cut costs, fend off competitors…
Many companies today are operating a balanced approach to target and phenotypic assays, to try to optimize for disease relevance and throughput. Last week my blog post set the scene on the HCS landscape, but with new phenotypic assay formats…
Leading Contract Development and Manufacturing Organization (CDMO) boosts number of users in line with company growth Boston, US & London, UK, March 8, 2016 – AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. (AAI/CML), now known as Alcami, a…
Prior to the 1980s the vast majority of drug discovery was performed on tissues, cells or living organisms, where the tests looked for how compounds effected the phenotype. Since then the industry has adopted in-vitro target based approaches, leveraging advancements…
IDBS have just returned from a productive and enjoyable trip to the Smartlab Exchange conference in Munich. The event provided the usual eclectic mix of attendees, speakers and exhibitors all combined together resulting in a successful two days for all…
Today’s bioanalytical (BA) scientists find themselves under a deluge of data. It’s no bad thing as this valuable asset is driving research and development (R&D) forward, but it’s only useful if that information is stored and curated consistently. Paper-based processes…
We’ve been gathering feedback, reviewing market trends, and meeting with customers and partners alike to drive our development priorities for the upcoming year. With the release of 10.1 in January, we’ve brought even more key functionality to the web and…
Web deployment will see leading biotech replace paper and protect IP Boston, US & London, UK, February 9, 2016 – Octapharma GmbH (‘Octapharma’), a leading biopharmaceuticals organization, has chosen E-WorkBook 10 from IDBS. The web-based electronic laboratory notebook (ELN…
Scientific Computing World February 2016 Find out more about our attendance at the SmartLab Exchange in Munich, to showcase the latest enhancements made to the E-WorkBook platform. Read the article here »About IDBSContact us More news…
Scientific Computing World February 2016 A drive for collaboration is creating new challenges for research organizations, right along the R&D value chain. Scott Weiss, Senior Director of Product Management at IDBS, speaks with Sophia Ktori about how E-WorkBook Connect can…
Scientific Computing World February 2016 Heading to the Paperless Lab Academy event in Barcelona, 19-20 April? Our VP Strategic Solutions, Paul Denny-Gouldson, will be running a workshop at the event – for more info head to Scientific Computing World. Read…
This is a question that is asked more often than you might think – and if it isn’t asked it should be asked whenever a project kicks off. So what to do – first of all you’ve got to understand…
As oil prices tumble below $40 a barrel, the upstream finds itself with significant challenges in terms of managing exploration and production costs, as well as the loss of IP due to downsizing. The greener alternative of biofuels (which competes…
Cloud-based portal enables secure, external collaboration Boston, US & London, UK, January 18, 2016 – IDBS has unveiled E-WorkBook Connect, a secure portal enabling R&D organizations to collaborate with external partners. A module of IDBS’ flagship E-WorkBook software, the…
As an IT company I want to make excellent software So that lots of customers will decide to buy our products. This is what we call a user story; a product requirement written from the point of view of the…
Scientific Computing World January 2016 Informatics are changing “quietly and profoundly”. IDBS spoke with Scientific Computing World about how ELNs are adapting to meet the evolving challenges of a complex R&D ecosystem. Read the article here »About IDBSContact us More…
Scientific Computing World January 2016 Paul Denny Gouldson, Vice President of Strategic Solutions at IDBS, shares his insights on document and knowledge management in the 2016 Laboratory Informatics Guide. Is the ELN about to reach its true potential? Read the…
Scientific Computing World January 2016 In the age of virtualized and collaborative research, integrating instruments and informatics is a significant step for R&D labs. Paul Denny-Gouldson spoke with Scientific Computing World about why cloud could be key. Read the article…
European Pharmaceutical Manufacturer Magazine December 2015 Change is afoot for Europe’s R&D ecosystem, from regulation changes and to competitive pressures and altered research practices. Paul Denny-Gouldson, Vice President Strategic Solutions at IDBS, discusses how technology…
2015 has been a busy year for IDBS, with the launch of E-WorkBook 10, our flagship research tool, and several customer and partner events across the world. These include Connect Philadelphia and our Community Forum series. For us, connecting with…
The Cell Culture Dish December 2015 Brandy Sargent discusses some of the key learnings and exhibitors at the latest BioProcess International Conference in Boston, MA – including IDBS, and the benefits of our revamped E-WorkBook platform. Read the article here…
Scientific Comupting November 2015 With the US and China pushing ahead on R&D investment and patent logging, is there still a place for Europe at the top table of R&D? Paul Denny-Gouldson shares his insights with Scientific Computing. Read the…
Financial Times November 2015 The Financial Times reports on how ActivityBase has helped leading drug-discovery company, Inventiva, to boost the speed of identifying new compounds and analysing data. Read the article here »About IDBSContact us More news…
I’ve worked with a number of customers on their vision for a ‘lab of the future’, but what does that really mean for bioprocess manufacturing? Despite the advances in data management technology, the prevalence of paper-based systems in biomanufacturing is…
Surrey Research Park newsletter October 2015 The latest Surrey Research Park newsletter explores how IDBS is embracing a Silicon Valley approach to innovation, and how it has grown into a 300-strong provider of advanced software to over 50,000 researchers in…
Recently we’ve discussed the changing nature of the research and development (R&D) business model and the advent of virtualized research. Across different industries as varied as pharmaceuticals, consumer goods and energy, organizations are motivated by a common drive to innovate…
Silicon Valley is a beacon of cutting-edge tech development. It conjures up images of agile, disruptive startups taking on the world and winning with their entrepreneurial gusto. It’s where category-defining tech innovators like Apple, Google, Kiip and Lyft’ have…
Organizations today are under a huge amount of pressure to improve efficiency and reduce costs. This means that business practices and how organizations want to capture and view their data are changing. In some cases, organizations are being asked to…
The TPP trade agreement involves 12 Pacific Rim nations accounting for 40% of the global economy including the US and Japan – with an accumulated population of roughly 800 million people. While business has broadly supported the deal and the…
The UK has tightened regulation for clinical trials in recent years. Reaction from the industry has been strong, with some suggesting legislation and high costs will kill off research and development (R&D) innovation and clinical research in the UK …
Lab Manager September 2015 Mike May looks into the growing importance of mobile features for electronic lab notebooks – featuring comments from VP Strategic Solutions, Paul Denny-Gouldson, and IDBS technology partner ACD/Labs. Read the article here »About IDBSContact us More…
BioPharma Dive September 2015 BioPharma Dive covers the recent appointment of our CTO, Peter Murray, and the deliberate shift IDBS is making to accelerate innovation and bring new products to the market. Read the article here »About IDBSContact us More…
Pharmaceutical and chemistry-related businesses have bemoaned the negative impact of regulation on innovation and, more recently, a decision to cut $2.4bn from the European Commission’s flagship science research program, Horizon 2020. In contrast, the US aims to increase its National…
The pitfalls of automating the past While moving to electronic systems for scientific data management brings clear benefits, the risks for organizations is that implementation seeks to automate past, paper-based processes. The result is that data goes from being…
Drug Discovery World July 2015 The discovery and development of drugs is changing. In the summer edition of Drug Discovery World, Paul Denny-Gouldson explores the challenges this presents for R&D organizations – and how they can be overcome. Read the…
When it comes to research and development (R&D), money talks. More specifically, cost will always play a role in the type of technologies used in the lab – and the way those technologies are used. As the media has often…
Research and Development (R&D) organizations are becoming more and more focused on innovation. In doing so, they are increasingly opening up their research infrastructures, forming cross-disciplinary diverse teams. The days of two or three pharmaceutical chemistry scientists sitting…
As outsourcing becomes more prevalent across scientific domains, and in the bioanalysis sphere in particular, the importance of effective collaboration tools has come to the forefront. More and more companies are turning to external providers to help cut costs and…
CTO blends agile start-up mentality with deep domain expertise Boston, US & London, UK, July 20, 2015 – IDBS today announced the appointment of Chief Technology Officer (CTO), Peter Murray. Responsible for the long term direction of IDBS’ vision…
For many scientific operations, day-to-day processes revolve around running assays, getting results and verifying that everything was completed according to the protocol. The challenge inherent in this has been the retrospective approach to quality control (QC). Today’s…
Strategic agreement streamlines integration within laboratory informatics systems Toronto, CANADA & London, UNITED KINGDOM (July 9 , 2015) – ACD/Labs, a Toronto-based chemistry software company, and IDBS, a leading global provider of advanced software for R&D organizations…
Scientific Computing June 2015 Paul Denny-Gouldson shares his insights with Scientific Computing on why a strategy shaped around ergonomics, automation and virtualization could make elements of the R&D ‘lab of the future’ a reality today. Read the article here »About…
Process development groups face challenges on several fronts: quickly developing and transferring robust processes, constant optimization, cutting down on errors and saving time and money. But with research and development (R&D) spend in many parts of the world hitting a…
As competitive pressures grow, innovation has become imperative for research and development (R&D) organizations. In this pursuit, the sharing and efficient use of data is key to ensuring greater efficiency and speed to market. It keeps the cogs of ‘knowledge…
What struck you most about this year’s IDBS Connect? Was it the news about the new collaboration, search and inventory management tools announced on the first day? Was it hearing customers in both the life sciences and industrial sectors share…
At the heart of research lies innovation. And at the heart of innovation lies disruptive change. In previous posts we’ve looked at the disruptive power of trends within IP protection and prosecution; how lab automation is changing the way R&D is done and…
Chemical & Engineering News May 2015 Rick Mullin, Senior Editor at C&EN, offers a roundup of key news and discussions from the recent Bio-IT World conference in Boston – including a new strategic partnership between IDBS and ChemAxon. Read the…
For some R&D decision makers, the ‘lab of the future’ conjures up images of endless cost and resources diverted to new and complex systems. To others the issue of mobility is at the forefront -like Pandora’s Box – best left…
Bio IT World April 2015 Last week’s Bio-IT World conference saw IDBS announce a technology partnership, integrating ChemAxon’s chemical sciences software into IDBS’ E-WorkBook and ActivityBase platforms. Read the article here »About IDBSContact us More news…
R&D Magazine April 2015 The growing emphasis on knowledge sharing presents new challenges to the R&D ecosystem. Ian Peirson, Senior Solutions Consultant at IDBS, shares his insights with R&D Magazine on how to keep the ‘knowledge management’ cogs turning. Read…
Strategic technology deal strengthens IDBS’ single R&D data management platform Boston, US, Budapest, Hungary & London, UK, April 22, 2015 – Today at Bio-IT World Conference & Expo 2015, IDBS announces a strategic technology partnership which sees ChemAxon’s…
In our latest guest blog, intellectual property (IP) lawyer, Andrés Jaramillo-Mejía talks us through the principles underpinning IP law and the need for reliable and robust documentation. Over two centuries of multilateral agreements and a host of supranational accords and…
Here at IDBS, we often talk about how we want to link data and people. But what do we really mean by that? It comes down to the fact that, data alone isn’t what drives innovation and delivers value to your…
Drivers such as the expiration of pharmaceutical patents, legal and regulatory reforms, and social and cost pressures have increased the value of intellectual property (IP). At the same time, new collaborative ways of working and the externalization of certain workflows…
A team of researchers recently published promising findings on ‘Eve’ – an artificially intelligent ‘robot scientist’ capable of screening potential drugs with almost no human input needed. Meanwhile, IBM’s artificially intelligent (AI) Watson system is seeing take-up among…
American Laboratory March 2015 Collaboration and joint ventures are on the rise in the petrochemical arena. As the popularity of biofuels grows in response, how can systems support this new demand? Paul Denny-Gouldson shares his insights with American Laboratory. Read…
This month AstraZeneca announced a move towards externalizing its business model and working with partners in a bid to reduce research and development (R&D) spend. It’s a sign of the times, as the pharma and biotech industries find themselves under significant budget…
The ideal research and development (R&D) data management solution can be deployed across different teams, geographies and even be used with external stakeholders. But often the cost of deployment and training is daunting. You may not realize just how…
Lab Manager March 2015 Lab Manager explores how IDBS has helped Lonza Biologics to integrate and optimize its bioprocess activities, managing the complete laboratory-to-report lifecycle within one single system: Bioprocess Execution System. Read the article here »About IDBSContact us…
We recently shared news about our internal day devoted to employee innovation – idbsCreate. We’re lucky to be able to count on a global team of motivated and talented individuals from our software development divisions through to sales, human resources and…
EPM magazine February 2015 Will the introduction of AI herald a new era for life sciences? Not quite – Eve is the latest evolution of this kind of technology, rather than a brand new concept. This is not a silver…
This year we’ll be heading to Philadelphia, USA from May 19 – 20. IDBS Connect is our premier annual customer event that brings together the most innovative and creative minds in the global research and development (R&D) sector. With both formal…
Scientific Computing World February/March 2015 Work in the R&D laboratory starts with an idea and an experiment, not a sample. Sophia Ktori speaks with Paul Denny-Gouldson, VP Strategic Solutions, and investigates how informatics are tailored to make life easier for…
Research and development (R&D) is changing. And with concepts such as the ‘lab of the future’ and the ‘paperless lab’ becoming more common, it’s important to understand what these terms really mean in practice. The lab of the future is…
GIT Laboratory Journal January 2015 At IDBS, the sights are firmly set on enabling collaboration, helping R&D organizations gain greater insight from their data and getting their products to market quicker. Read the article here »About IDBSContact us More news…
At the end of 2014, the entire staff of IDBS were given the opportunity to spend a day innovating. And when I say the entire staff, we mean everyone: from the front desk team all the way up to the…
European Pharmaceutical Review January 2015 The secure and robust management of intrinsically complex cell-based screening data is paramount to ensure confidence in results and subsequent decision-making. ActivityBase has long been regarded as the gold standard in biological high volume…
Evolution of platform delivers streamlined work environment and foundation for the future London, UK, and Boston, US, January 19, 2015 – IDBS has completely revitalized its ELN software for multidisciplinary research and development (R&D). A technology overhaul in E-WorkBook…
The New Year is already in full swing and as we move wholeheartedly into 2015, a look into the crystal ball shows exciting developments for research and development (R&D) across all domains. Will this be the year that scientists cure…
Laboratory Informatics Guide 2015 January 2015 Scientific Computing World’s annual Laboratory Informatics Guide lifts the lid on the industry’s hot topics of the year, providing insight into change management, integration and hosted data solutions. Included in the guide is Paul…
Laboratory Informatics Guide 2015 January 2015 Scientific Computing World’s annual Laboratory Informatics Guide lifts the lid on the industry’s hot topics of the year, providing insight into change management, integration and hosted data solutions. Included in the guide is Paul…
Lab Manager January 2015 In order to boost collaboration, traceability and quality of data within the organization, Netherlands-based BiCHEM decided to ditch paper notebooks and manual processes in favor of E-WorkBook. We explain the challenges they faced under their old…
The Cell Culture Dish January 2015 Process development groups need a blend of flexibility and structured data not offered by traditional lab systems. Jarrod Medeiros, senior solutions consultant at IDBS, talks through data management in biologics development. Read the article…
The holidays are upon us and, in among the tinsel and turkey, the end of the year is just around the corner. Before the clock strikes midnight to usher in 2015, let’s take a quick look back at just…
Drug development in the UK took center stage recently, as life sciences minister George Freeman set out his initiatives to make Britain “the best place in the world to get quicker access for patients to innovative medicines”. The Government also announced…
The move towards automation has been a key trend in the pharma and biotech sectors. We’ve seen the robotic handling and processing of samples move from high-throughput screening domains onto the discovery bench. Almost every lab now has a liquid…
Data. It’s everywhere and every day, more and more is being generated by scientists in research and development (R&D) cell culture labs. This data is a highly valuable asset so long as it can be accessed and linked together efficiently…
We are bombarded with tips and tricks for living a healthier lifestyle every single day. In recent years we have seen a shift in attitudes from fast food
